Patient Out-of-Pocket Spending on Generic and Brand-Name Prescription Drugs

Cai CL, Kesselheim AS, Rome BN - JAMA Network Open

  • Price, Value, and Access

Summary:

Policy efforts typically focus on improving affordability for brand-name medications, but this analysis of national survey data found that more than half of out-of-pocket spending by US patients is on generic drugs. Although generic medications are typically less expensive, they account for 90% of dispensed fills. More efforts may be warranted to improve the affordability of generic medications in the US.

VIEW SOURCE

Recent Work from PORTAL

Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Pharmaceutical Industry Pay-Per-Click Advertising Strategies to Influence Public Opinions on Drug Pricing

Eisenkraft Klein D, Kesselheim AS - Clinical Pharmacology & Therapeutics

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Coverage and Costs for Medications After Medicare Price Negotiation

Cai CL, Bucha S, Kesselheim AS, Rome BN - Journal of General Internal Medicine

  • Price, Value, and Access
Simple graphic of magnifying glass examining papers to signify reviewing research publications.

Methodological Divergence in Oncology HTA: Implications for International Harmonization and the Handling of Uncertainty

Chen NC, Bullement A, Zemplenyi AT, O'Bryant CL, Kaizer AM, Anderson KE, McQueen RB - PharmacoEconomics Open

  • Price, Value, and Access